View by Specialty

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

Cirrhosis/Liver Failure News

SPONSORED CONTENT
Save
SPONSORED CONTENT
November 28, 2017
1 min read
Save

Non-invasive MRI for liver disorders receives expanded FDA clearance

Perspectum Diagnostics Ltd. received 510(k) clearance from the FDA for LiverMultiScan, a post-processing software device for MRI of the liver, which will expand its access to more patients with liver disorders who can benefit from non-invasive diagnostic aid, according to a press release.

SPONSORED CONTENT
November 22, 2017
3 min read
Save

Drinking coffee reduces risk for death, negative health outcomes

Consuming coffee lowered the risk for death and a broad spectrum of health outcomes, according to a report recently published in BMJ.

Trending

Anthony A. Romeo
November 15, 2024
4 min read
Save

Capitalism is the path to value-based care

SPONSORED CONTENT
November 16, 2017
4 min read
Save

Moderate coffee intake reduces risk for liver cancer, cirrhosis, fibrosis

Moderate coffee intake reduces risk for liver cancer, cirrhosis, fibrosis

In a roundtable format, experts gathered to discuss the latest research on coffee and liver disease, which indicate that drinking approximately three to five cups per day is associated with a reduced risk for hepatocellular carcinoma, cirrhosis and fibrosis.

SPONSORED CONTENT
November 08, 2017
2 min read
Save

Bacterial infections frequently occur in acute-on-chronic liver failure

In a recent study, two-thirds of patients with acute-on-chronic liver failure either presented with bacterial infections or developed them during follow-up, revealing that such infections are significantly common in this cohort.

SPONSORED CONTENT
November 03, 2017
2 min read
Save

Model accurately predicts cirrhosis-driven hepatic encephalopathy

Model accurately predicts cirrhosis-driven hepatic encephalopathy

A recently published study reports on the development of two risk-score models to predict the 1-year and 5-year probability for hepatic encephalopathy in patients with cirrhosis, based on statin use and total bilirubin and albumin.

SPONSORED CONTENT
November 02, 2017
2 min read
Save

Psoriasis, inflammatory diseases increase risk for cirrhosis, fatty liver

Psoriasis, inflammatory diseases increase risk for cirrhosis, fatty liver

Patients with inflammatory disorders, especially psoriasis and psoriatic arthritis, had an elevated risk for severe liver disease such as nonalcoholic fatty liver disease and cirrhosis, according to a recently published study.

SPONSORED CONTENT
October 25, 2017
3 min watch
Save

VIDEO: Expert reviews promising treatment data from The Liver Meeting 2017

VIDEO: Expert reviews promising treatment data from The Liver Meeting 2017

WASHINGTON, D.C. — In this exclusive video from The Liver Meeting 2017, Kris V. Kowdley, MD, FAASLD, of the Swedish Medical Center, Liver Care Network, Seattle, highlights some of the ground-breaking presentations from the meeting.

SPONSORED CONTENT
October 25, 2017
2 min watch
Save

VIDEO: Alcohol misuse, related cirrhosis increasing in U.S.

VIDEO: Alcohol misuse, related cirrhosis increasing in U.S.

WASHINGTON — In this exclusive video from The Liver Meeting 2017, Jessica L. Mellinger, MD, from the department of Internal Medicine-Hepatology at the University of Michigan, discusses the increasing rates of alcohol use disorders and alcoholic cirrhosis in the U.S.

SPONSORED CONTENT
October 24, 2017
4 min read
Save

Mobile monitoring reduces preventable cirrhosis readmissions

WASHINGTON — A novel mobile device monitoring system reduced 30- and 90-day cirrhosis-related readmissions with no potentially preventable readmissions in this pilot study at 90 days, according to data presented at The Liver Meeting 2017.

SPONSORED CONTENT
October 23, 2017
3 min read
Save

Early liver transplant in severe alcoholic hepatitis shows benefit

WASHINGTON — Early liver transplant in patients with severe alcoholic hepatitis demonstrated acceptable short-term survival, according to results from the multi-center ACCELERATE-AH study presented at The Liver Meeting 2017.

View more